# Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder

> **NCT05529927** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Parnassia Addiction Research Centre** · enrollment: 204 (estimated)

## Conditions studied

- Cocaine Use Disorder

## Interventions

- **DRUG:** Sustained-release Dexamphetamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05529927
- **Lead sponsor:** Parnassia Addiction Research Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2029-01
- **Final completion:** 2029-10
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05529927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05529927, "Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05529927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*